NCT00068458

Brief Summary

RATIONALE: A home-based exercise and/or diet program may improve the quality of life of breast cancer patients by preventing an increase in body fat and weight and a loss of lean body tissue. PURPOSE: This randomized phase II trial is studying the effectiveness of three home-based diet and/or exercise programs in preventing weight gain and loss of muscle tissue in women who are receiving chemotherapy for stage I, stage II, or stage IIIA breast cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for phase_2 breast-cancer

Timeline
Completed

Started Sep 2003

Shorter than P25 for phase_2 breast-cancer

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2003

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

September 10, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 11, 2003

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2004

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2005

Completed
Last Updated

December 19, 2017

Status Verified

April 1, 2013

Enrollment Period

4 months

First QC Date

September 10, 2003

Last Update Submit

December 15, 2017

Conditions

Keywords

weight changesdepressionstage I breast cancerstage II breast cancerstage IIIA breast cancer

Outcome Measures

Primary Outcomes (1)

  • Distance Medicine Based Diet Exercise Program Within the Cooperative Group Setting

    Assess estimates of effect sizes and to ascertain potential feasibility of implementing a distance-medicine based diet-exercise program within the cooperative group setting.

    6 months

Study Arms (3)

Arm 1: calcium diet

ACTIVE COMPARATOR

Calcium-Rich Diet (dietary counseling + materials promoting an intake of 1,200 - 2,500 mg/day).

Dietary Supplement: Calcium-Rich Diet

Arm 2: Exercise + Calcium-Rich Diet

ACTIVE COMPARATOR

Exercise + Calcium Rich Diet (dietary counseling + materials promoting strength training and aerobic activity + a calcium intake of 1,200 - 2,500 mg/day).

Other: Arm 2: Exercise + Calcium-Rich Diet

Exercise + Fruit & Vegetable, Low Fat + Calcium Diet

ACTIVE COMPARATOR

Dietary counseling + materials promoting strength training and aerobic activity + a diet that has \< 20% of energy coming from fat and intakes of fruits and vegetables of \> 5 servings/day + a calcium intake of 1,200 - 2,500 mg/day. 6 month intervention.

Other: Exercise + Fruit & Vegetable, Low Fat + Calcium Diet

Interventions

Calcium-Rich DietDIETARY_SUPPLEMENT

1,200 - 2,500 mg/day. 6 month intervention

Also known as: Calcium
Arm 1: calcium diet

Dietary counseling + material promoting strength training an aerobic activity + a calcium intake of 1,200 - 2,500 mg/day. 6 month intervention.

Also known as: Calcium
Arm 2: Exercise + Calcium-Rich Diet

1,200 - 2,500 Calcium intake per day. 6 month intervention period.

Also known as: Calcium
Exercise + Fruit & Vegetable, Low Fat + Calcium Diet

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
DISEASE CHARACTERISTICS: * Histologically confirmed breast cancer * Stage I, II, or IIIA * Scheduled to receive adjuvant chemotherapy OR received 1 prior course of chemotherapy * Hormone receptor status: * Not specified PATIENT CHARACTERISTICS: Age * 18 and over Sex * Female Menopausal Status * Premenopausal, defined as at least 1 of the following: * Less than 4 months since last menstrual period at diagnosis * Follicle-stimulating hormone level in the premenopausal range Performance status * Not specified Life expectancy * Not specified Hematopoietic * Not specified Hepatic * Not specified Renal * No calcium-based kidney stones Cardiovascular * No angina within the past 6 months * No myocardial infarction within the past 6 months * No abnormal MUGA and/or stress test Other * Not pregnant or nursing * Access to a telephone * Able to read and speak English * No other prior or concurrent malignancy except curatively treated carcinoma in situ of the cervix or nonmelanoma skin cancer * No history of hyperthyroidism or hypothyroidism * No paralysis * No osteoarthritis with uncontrolled joint pain that would preclude exercise * No diverticulitis * No serious medical or psychiatric illness that would preclude giving informed consent or completing study therapy or quality of life questionnaires * No medical condition that would interfere with body composition assessment * No medical condition for which unsupervised exercise is contraindicated * No medical condition for which a high vegetable and fruit diet or a calcium-rich diet is contraindicated PRIOR CONCURRENT THERAPY: Biologic therapy * Not specified Chemotherapy * See Disease Characteristics Endocrine therapy * Not specified Radiotherapy * Not specified Surgery * No prior bilateral oophorectomy * No prior amputation * No concurrent transverse rectus abdominis myocutaneous surgery * No concurrent surgery Other * No concurrent blood-thinners (e.g., coumadin or warfarin)

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (4)

Duke Comprehensive Cancer Center

Durham, North Carolina, 27710, United States

Location

Southeastern Medical Oncology Center

Goldsboro, North Carolina, 27534, United States

Location

Comprehensive Cancer Center at Wake Forest University

Winston-Salem, North Carolina, 27157-1030, United States

Location

Cancer Centers of the Carolinas - Eastside

Greenville, South Carolina, 29615, United States

Location

Related Publications (1)

  • Demark-Wahnefried W, Case LD, Blackwell K, Marcom PK, Kraus W, Aziz N, Snyder DC, Giguere JK, Shaw E. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer. 2008 Feb;8(1):70-9. doi: 10.3816/CBC.2008.n.005.

MeSH Terms

Conditions

Breast NeoplasmsDepressionBody Weight Changes

Interventions

CalciumExerciseFruitVegetablesDiet, Fat-Restricted

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBehavioral SymptomsBehaviorBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Metals, Alkaline EarthElementsInorganic ChemicalsMetalsBlood Coagulation FactorsBiological FactorsMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological Phenomena

Study Officials

  • Edward G. Shaw, MD

    Wake Forest University Health Sciences

    STUDY CHAIR
  • Wendy Demark-Wahnefried, PhD

    Duke Cancer Institute

    PRINCIPAL INVESTIGATOR
  • Roger T. Anderson, PhD

    Wake Forest University Health Sciences

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2003

First Posted

September 11, 2003

Study Start

September 1, 2003

Primary Completion

January 1, 2004

Study Completion

January 1, 2005

Last Updated

December 19, 2017

Record last verified: 2013-04

Locations